HEXALEN DIN 02126230
Health Canada record
| Active ingredient(s) | ALTRETAMINE 50 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XX03 ALTRETAMINE |
| Original market date | 31-Dec-1995 |
| Current status date | 09-Sep-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Eisai Limited — licence 101843, currently licensed, last inspection rating C (2023-03-29).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1693 | 2001-02-15 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 965 | 2000-04-20 | New Drug Submission (NDS) | |
| 5165 | 1994-08-09 | New Drug Submission (NDS) |
International API supply for ALTRETAMINE
0 active FDA Drug Master Files.
Request a quote for HEXALEN